REM-001

REM-001 · Kintara Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for REM-001, covering 2025-08-28 to 2025-08-28. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety Study of REM-001 Photodynamic Therapy for Treatment of Cutaneous Metastatic Breast Cancer (CMBC) [Phase 2]

See pricing